Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro
Open Access
- 1 November 1998
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 78 (9) , 1194-1198
- https://doi.org/10.1038/bjc.1998.653
Abstract
Several reverse transcriptase polymerase chain reaction (RT-PCR) assays have been described for the detection of circulating tumour cells in blood and bone marrow. Target mRNA sequences for this purpose are the cytokeratins (CK) 19 and 20, the carcinoembryonic antigen (CEA), and the prostate-specific antigen messages. In this study, we investigated biological factors influencing the specificity of the CK19 and CEA RT-PCR assays. Bone marrow, granulocyte colony-stimulating factor (G-CSF)-mobilized blood stem cells and peripheral blood samples obtained from healthy volunteers (n = 15; CEA n = 7), from patients with epithelial (n = 29) and haematological (n = 23) cancer and from patients with chronic inflammatory diseases (n = 16) were examined. Neither CEA nor cytokeratin 19 messages could be amplified from bone marrow samples from healthy subjects and from patients with haematological malignancies. In contrast, specimens from patients with inflammatory diseases scored positive up to 60%. To investigate the influence of inflammation on target mRNA expression, haemopoietic cells were cultured with and without cytokine stimulation in vitro. CK19 messages could be easily detected in cultured marrow cells without further stimulation, CEA messages only after gamma-interferon (gamma-INF) stimulation. In contrast, G-CSF-mobilized peripheral blood stem cells were positive for CK19 messages only after stem cell factor (SCF) or interleukin stimulation. We conclude that transcription of so-called tissue-specific genes is inductible in haemopoietic tissues under certain conditions. These factors have to be considered in future applications of RT-PCR for the detection of minimal residual disease.Keywords
This publication has 18 references indexed in Scilit:
- Sensitive and specific cytokeratin 18 reverse transcription-polymerase chain reaction that excludes amplification of processed pseudogenes from contaminating genomic DNAClinical Chemistry, 1997
- Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patientsZeitschrift für Krebsforschung und Klinische Onkologie, 1996
- The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of diseaseInternational Journal of Cancer, 1996
- Detection of Minimal Disease in Patients with Solid TumorsJournal of Hematotherapy, 1996
- Diagnosis of micrometastases by the amplification of tissue-specific genesGene, 1995
- Sensitive Detection of Prostatic Hematogenous Tumor Cell Dissemination Using Prostate Specific Antigen and Prostate Specific Membrane-Derived Primers in the Polymerase Chain ReactionJournal of Urology, 1995
- Cytokine mediators of septic infections in the normal and granulocytopenic hostEuropean Journal of Haematology, 1993
- Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reactionThe Lancet, 1991
- Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies.Proceedings of the National Academy of Sciences, 1987
- 2. Internationales Expertentreffen der Deutschen Stiftung für Krebsforschung ‘Current Trends in Cancer Research’Oncology Research and Treatment, 1980